Nos articles

Effectiveness of conversional metabolic and bariatric surgery on dyslipidemia and the cost of lipid‑lowering medications over 4 years: a French nationwide study. 

Thereaux J, Bennani M, Khemis J, Ohayon E, Buissez IV, Lafourcade A, Quiriconi L, Philippe C, Oppert JM. 

Surg Obes Relat Dis. 2024 Dec;20(12):1270‑1278.

Evaluating the impact and costs of conversional or revisional metabolic bariatric surgery on obstructive sleep apnea: Insights from a French nationwide cohort. 

Thereaux J, Bennani M, Khemis J, Ohayon E, Buissez IV, Lafourcade A, Quiriconi L, Philippe C, Oppert JM. 

Surgery. 2024 Nov;176(5):1337‑1344. 

Attributes for a discrete‑choice experiment on preferences of patients for oncology pharmacy consultations. 

Damerval M, Bennani M, Rioufol C, Omrani S, Riboulet M, Etienne‑Selloum N, Saint‑Ghislain A, Leenhardt F, Schmitt A, Simon N, Clairet AL, Meurisse A; French Implication Expert Panel; Nerich V. 

Support Care Cancer. 2024 Apr 30;32(5):318. 

Cost‑Effectiveness of Sleeve Gastrectomy and Gastric Bypass as Revisional Surgery on Antidiabetic Reimbursement: A Nationwide Cohort Study.

Thereaux J, Bennani M, Khemis J, Ohayon E, Visnovec Buissez I, Lafourcade A, Quiriconi L, Philippe C, Oppert JM. 

Ann Surg Open. 2024 Apr 11;5(2):e420. 

Patient Preferences for Pharmacy Services: A Systematic Review of Studies Based on Discrete Choice Experiments. 

Riboulet M, Clairet AL, Bennani M, Nerich V. 

Patient. 2024 Jan;17(1):13‑24. 

Amylo‑AFFECT‑QOL, a self‑reported questionnaire to assess health‑related quality of life and to determine the prognosis in cardiac amyloidosis. 

Kharoubi M, Bézard M, Broussier A, Galat A, Gounot R, Poullot E, Molinier‑Frenkel V, Fanen P, Funalot B, Itti E, Lemonnier F, Sing Chadha GD, Guendouz S, Mallet S, Zaroui A, Audard V, Audureau E, Le Corvoisier P, Hittinger L, Planté Bordeneuve V, Lefaucheur J‑P, Amiot A, Bequignon E, Bartier S, Leroy V, Teiger E, Oghina S, Damy T.

Front Cardiovasc Med. 2023 Mar 14:10:1124660.

Real‑Life Evaluation of an Algorithm for the Diagnosis of Cardiac Amyloidosis.

Bézard M, Kharoubi M, Galat A, Le Bras F, Poullot E, Molinier‑Frenkel V, Fanen P, Funalot B, Moktefi A, Abulizi M, Deux JF, Lemonnier F, Guendouz S, Chalard C, Zaroui A, Itti E, Hittinger L, Teiger E, Oghina S, Damy T. 

Mayo Clin Proc. 2023 Jan;98(1):48‑59.

Benefits of Homeopathic Complementary Treatment in Patients With Breast Cancer: A Retrospective Cohort Study Based on the French Nationwide Healthcare Database.

Medioni J, Scimeca D, Marquez YL, Leray E, Dalichampt M, Hoertel N, Bennani M, Trempat P, Boujedaini N. 

Clin Breast Cancer. 2023 Jan;23(1):60‑70

Patient Perception of the Diagnosis Announcement and its Impact on Quality of Life of Patients with Primary Melanoma or Basal Cell Carcinoma.

Aymonier M, Taieb C, Corgibet F, Joly P, Sei JF, Chaussade V, Philippe C, Ezzedine K, Richard MA. 

Acta Derm Venereol. 2022 May 19;102:adv00717

How to define Mild to severe Hidradenitis Suppurativa? A simple new tool based on latent class analysis of EPIVER data study. 

Perrot JL, Maccari F, Guillem P, Fougerousse AC, Nassif A, Beneton N, Cinotti E, Girard C, Binois R, Reguiaï A. 

Clinical, cosmetic and investigational dermatology 2022:15 1091-1103

COPEDOL: A two‑year observational study in pretreated HIV‑1-infected patients switching to a dolutegravir‑based regimen. 

Landman R, Marcelin AG, Bennani M, Philippe C, Kousignian P, Finkielsztejn L, Roustand L, Nachbaur G, Pourcher V. 

Infect Dis Now. 2022 Mar;52(2):93‑100. 

History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosis.

Kharoubi M, Bézard M, Galat A, Le Bras F, Poullot E, Molinier‑Frenkel V, Fanen P, Funalot B, Moktefi A, Lefaucheur JP, Abulizi M, Deux JF, Lemonnier F, Guendouz S, Chalard C, Zaroui A, Audard V, Bequignon E, Bodez D, Itti E, Hittinger L, Audureau E, Teiger E, Oghina S, Damy T. 

ESC Heart Fail. 2021 Dec;8(6):5501‑5512. 

Prevalence of comorbidities in atopic dermatitis and psoriasis in the French population. 

Richard MA, Sei JF, Philippe C, Taieb C, Joly P, Ezzedine K. 

Ann Dermatol Venereol. 2021 Jan 23:S0151-9638(20)30191-5. 

Natural history and impact of treatment with tafamidis on major cardiovascular outcome‑free survival time in a cohort of patients with transthyretin amyloidosis. 

Bézard M, Kharoubi M, Galat A, Poullot E, Guendouz S, Fanen P, Funalot B, Moktefi A, Lefaucheur JP, Abulizi M, Deux JF, Gendre T, Audard V, El Karoui K, Canoui‑Poitrine F, Zaroui A, Itti E, Teiger E, Planté‑Bordeneuve V, Oghina S, Damy T. 

Eur J Heart Fail. 2020 Oct 23.

The Infantile Hemangioma Referral Score: A Validated Tool for Physicians. 

Léauté‑Labrèze C, Baselga Torres E, Weibel L, Boon LM, El Hachem M, van der Vleuten C, Roessler J, Troilius Rubin A. 

Pediatrics. 2020 Apr;145(4):e20191628. 

Création et validation d’un outil d’évaluation du handicap lié à l’atteinte du visage de la sclérodermie systémique.

M.‑S. Doutre, D. Godard, M. Benani, C. Taieb. 

Annales de Dermatologie et de Vénéréologie, Volume 147, Issue 10, 2020, Pages 595‑601, ISSN 0151‑9638, 

A Method for Designing a Patient Burden Questionnaire in Dermatology. 

Ezzedine K, Bennani M, Shourick J, Taieb C. 

Clin Cosmet Investig Dermatol. 2020 Aug 6;13:521-528. 

A prospective observational study on perioperative use of antibacterial agents in implant surgery.

Dominiak M, Shuleva S, Silvestros S, Alcoforado G. 

Adv Clin Exp Med. 2020 Mar;29(3):355‑363. 

Treatment of invasive fungal infections in intensive care units with micafungin: The MYRIADE study. Timsit JF, Leverger G, Milpied N, Gachot B. 

Mycoses. 2020 May;63(5):443‑451. 

Along with the French national network on rare skin diseases (FIMARAD). Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.

Armand ML, Taieb C, Bourgeois A, Bourlier M, Bennani M, Bodemer C, Wolkenstein P. 

Orphanet J Rare Dis. 2019 May 3;14(1):94. 

Filière Maladies Rares en Dermatologie. Incontinentia pigmenti burden scale: designing a family burden questionnaire.

Taieb C, Hadj‑Rabia S, Monnet J, Bennani M, Bodemer C. 

Orphanet J Rare Dis. 2019 Nov 26;14(1):271. 

Palmoplantar keratoderma: creating a disease burden questionnaire.

Hickman G, Bodemer C, Bourrat E, Bennani M, Taieb C. 

J Eur Acad Dermatol Venereol. 2019 Aug;33(8):e291‑e293. 

Sex- and age‑adjusted prevalence estimates of skin types and unpleasant skin sensations and their consequences on quality of life: results of a study of a large representative sample of the French population.

Misery L, Ezzedine K, Corgibet F, Dupin N, Sei JF, Philippe C, Joly P, Taieb C, Richard MA. 

Br J Dermatol. 2019 Jun;180(6):1549‑1550. 

Use of Micafungin for the Prevention and Treatment of Invasive Fungal Infections in Everyday Pediatric Care in France: Results of the MYRIADE Study.

Leverger G, Timsit JF, Milpied N, Gachot B. 

Pediatr Infect Dis J. 2019 Jul;38(7):716‑721. 

Development and validation of a new tool to assess the Burden of Sensitive Skin (BoSS).

Misery L, Jourdan E, Abadie S, Ezzedine K, Brenaut E, Huet F, Sayag M, Taieb C. 

J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2217‑2223. 

Filière Maladies Rares en Dermatologie : FIMARAD. Burden of albinism: development and validation of a burden assessment tool.

Morice‑Picard F, Taïeb C, Marti A, Gliksohn A, Bennani M, Bodemer C, Ezzedine K. 

Orphanet J Rare Dis. 2018 Sep 18;13(1):162. 

Evaluating patient preference and satisfaction for human immunodeficiency virus therapy in France. 

Brégigeon‑Ronot S, Cheret A, Cabié A, Prazuck T, Volny‑Anne A, Ali S, Bottomley C, Finkielsztejn L, Philippe C, Parienti JJ. 

Patient Prefer Adherence. 2017 Jul 10;11:1159-1169.

Les anti arthrosiques d’action lente et les compléments alimentaires à visée articulaire : quelles différences ?

Marty M, Richette P, Bennani M, Chevalier X. 

Réflexions Rhumatologiques, N°181, avril 2016

The Vitiligo Impact Patient Scale (VIPs): Development and Validation of a Vitiligo Burden Assessment.

Salzes C, Abadie S, Seneschal J, Whitton M, Meurant JM, Jouary T, Ballanger F, Boralevi F, Taieb A, Taieb C, Ezzedine K. 

Tool. J Invest Dermatol. 2016 Jan;136(1):52‑8. 

Impact of falling reimbursement rates on physician preferences regarding drug therapy for osteoarthritis using a discrete choice experiment. 

Berchi C, Degieux P, Halhol H, Danel B, Bennani M, Philippe C. 

Int J Pharm Pract. 2016 Apr;24(2):114‑22. 

Physicians' preferences for prescribing oral and intravenous anticancer drugs: a Discrete Choice Experiment. 

Benjamin L, Cotté FE, Philippe C, Mercier F, Bachelot T, Vidal‑Trécan G. 

Eur J Cancer. 2012 Apr;48(6):912‑20.